Lake Street Maintains Buy on Hyperfine, Raises Price Target to $2.5
3/19/2026
Impact: 70
Healthcare
Lake Street analyst Frank Takkinen has maintained a Buy rating on Hyperfine (NASDAQ: HYPR) and increased the price target from $2 to $2.5.
AI summary, not financial advice
Share: